AstraZeneca (AZN) chief executive Pascal Soriot is grousing that he is not paid as much as his peers. “The truth is I’m the lowest-paid CEO in the whole industry,” he tells The Sunday Times. “It is annoying to some extent. But at the end of the day it is what it is.” Last year, his compensation totaled about $13.4 million, down from roughly $18.8 million the year before. “There’s other things in life than money. I’m not going to complain but me and Emma are the lowest paid in Europe and the U.S.,” he adds, referring to GlaxoSmithKline (GSK) Emma Walmsley.